Navigation Links
Genedata Announces Aptevo Therapeutics Deploys Genedata Biologics to Streamline Cancer Immunotherapy R&D
Date:8/21/2018

Genedata, a leading provider of advanced software solutions for biopharma R&D, today announced that Seattle-based Aptevo Therapeutics, a clinical-stage biotechnology company, has adopted Genedata as their preferred bioinformatics solution provider. Aptevo will use the Genedata Biologics® platform to facilitate expansion of their pipeline of novel bispecific antibody candidates focused on immuno-oncology, autoimmune disease and inflammation.

“To increase the throughput of our bispecific discovery program we needed a flexible E2E workflow system that could support our proprietary discovery technologies and ADAPTIR™ protein therapeutic platform,” said Dr. Peter Pavlik, Director of Molecular Biology and Protein Engineering Research at Aptevo. “We determined that Genedata Biologics was the best solution to fully address all our unique workflow requirements as it enables scale up of the screening, engineering, production and testing of complex multi-specific antibody candidates.”

“We appreciate Genedata Biologics’ flexible business model, which made it possible for a company of our size to adopt a market-leading platform solution,” said William Benjamin, IT Director at Aptevo. “As an established, off-the-shelf product, Genedata Biologics could be deployed across our organization with minimal customization. Also, this cloud-based solution was particularly appealing because of the rapid implementation it offered. We are very pleased with Genedata’s strong commitment to service and technical support and look forward to a long and productive partnership.”

“We are excited to work with Aptevo, an innovative leader in the development of novel immunotherapies. This partnership illustrates how Genedata works with future industry leaders who need a platform for scale up and automation of their R&D operations as they grow as an organization,” said Dr. Othmar Pfannes, CEO of Genedata. “We are committed to helping our partners – both large and small – be innovative and at the same time efficient.”

Since its first release in 2011, Genedata Biologics has been rapidly adopted by the majority of the world’s leading biopharmaceutical companies, as well as emerging specialty biotech companies. Genedata’s collaborations range from single group installations to large, global, multi-site partnerships and include technology transfer, customizations, project management, training, and roll out and deployment support.

Editorial Note
On August 21 at 11:20 EDT, Genedata Biologics will be featured at the Bispecific Antibody Pipeline Congress in the presentation “Bispecific Platform Designed for Rapid Development and Manufacturing of Novel Protein Therapeutics” by Peter Pavlik, PhD, Principle Scientist, Aptevo Therapeutics.
To schedule a briefing, contact biologics@genedata.com.

About Genedata
Genedata transforms data into intelligence with innovative software solutions and domain-specific consulting services that automate complex, large-scale experimental processes and enable organizations to maximize the ROI from their R&D. Founded in 1997, Genedata is headquartered in Switzerland and has offices in Germany, the UK, Japan, and the US.
http://www.genedata.com
Follow Us on LinkedIn

Disclaimer
The statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to contract cancellations, developing risks, competitive factors, uncertainties pertaining to customer orders, demand for products and services, development of markets for the Company's products and services. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

All product and service names mentioned are the trademarks of their respective companies.

Read the full story at https://www.prweb.com/releases/genedata_announces_aptevo_therapeutics_deploys_genedata_biologics_to_streamline_cancer_immunotherapy_r_d/prweb15698170.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology news :

1. Merck Animal Health announces Vetsulin
2. AAPS announces 2013 National Biotechnology Conference award winners
3. PLOS announces Accelerating Science Award Program
4. DFG announces recipients of 2013 Heinz Maier-Leibnitz Prize
5. Missouri Botanical Garden program announces collaboration with LHerboretum
6. Scripps Research announces research & license agreement with Janssen Pharmaceuticals
7. Chiltern Announces The Promotion Of Alecia Barbee To VP, Global Biometrics
8. DigitalPersona Announces U.are.U Software Development Kit (SDK) for Android Applications
9. PatientStream announces the industrys first Multilingual family waiting room board
10. Wiley announces increase in Impact Factors
11. Xyngular Announces the Launch of its New Xyng Enhanced Formula
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/23/2018)... Calif. (PRWEB) , ... August 21, 2018 , ... ... engineer the genomes of diverse cell types and species for the robust functional ... research tool for the development of T-cell based immunotherapies, the study of the ...
(Date:8/23/2018)... ... ... is proud to have hosted a variety of groups this year – both new guests ... Hewlett Packard, Sequenom and more, have all visited the La Jolla-based venue time and time ... reason clientele return is due to Lajollacooks4u’s signature team-building format, a way for teams to ...
(Date:8/21/2018)... ... August 20, 2018 , ... ... for biopharma R&D, today announced that Seattle-based Aptevo Therapeutics , a ... Aptevo will use the Genedata Biologics ® platform to facilitate expansion ...
Breaking Biology News(10 mins):
(Date:8/31/2018)... ... August 30, 2018 , ... Small, wireless and networked describes more ... and getting connected, too. Draper’s latest system is tiny in size, but is poised ... driving factor in the new implant design is the growing awareness that disease often ...
(Date:8/29/2018)... ... August 28, 2018 , ... Inc. Magazine has announced that ... in 1138th place on the 27th annual Inc. 5000, the most prestigious ranking ... most successful companies within the American economy’s most dynamic segment – independent small ...
(Date:8/29/2018)... SANTA BARBARA, Calif. (PRWEB) , ... August 28, 2018 , ... ... process optimization firm for the life sciences and healthcare industries, announces that Manu Vohra ... CA on August 30th. , What: “How to Implement Box for GxP in ...
(Date:8/23/2018)... , ... August 22, 2018 , ... ... for Android on September 1st, making it the first fully-featured app for electronic ... Android devices. Combined, iOS and Android constitute 99 percent of the market share ...
Breaking Biology Technology: